Skip to content
★ Sign in to follow
ED
Total declarations
31
Company
1
▲ Purchases (1 ops.)
€3,439
▼ Sales (12 ops.)
€2.0M

Latest filing published 09 May 2018 for AtriCure, Inc., €78k.

Filing timeline

BuySale
Elizabeth D. Krell

Insider track record

Disclosed buys
1
Disclosed sells
12
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 10 Jun 2008 · 6726 days ago · €3,439
    -66.9%
    Entry US$10.28 · Close at T+365 US$3.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Elizabeth D. Krell: trading record in brief

This profile gathers the share dealings of Elizabeth D. Krell in AtriCure, Inc. Between 10 June 2008 and 8 May 2018, the trades on record add up to 31 filings.

Market trades split into 1 purchase (€3,439) and 12 sales (€2.0M). Netting one side against the other leaves €2.0M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 4 share grants and 14 option exercises. Since January 2018: no purchases and 2 sales on the market.

The newest entry dates from 9 May 2018: an open-market sale of €192k, in AtriCure, Inc. The most recent open-market purchase was published on 10 June 2008, 6,726 days ago. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Elizabeth D. Krell

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations31 total

25 of 31 declarations